styramate

{{short description|Chemical compound}}

{{Drugbox

| verifiedrevid = 447817592

| IUPAC_name = (2-hydroxy-2-phenylethyl) carbamate

| image = Styramate.svg

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 94-35-9

| ATC_prefix = M03

| ATC_suffix = BA04

| PubChem = 7186

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = CBK7Y28SP3

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D07274

| ChemSpiderID = 6918

| C=9 | H=11 | N=1 | O=3

| smiles = C1=CC=CC=C1C(COC(=O)N)O

| StdInChI = 1S/C9H11NO3/c10-9(12)13-6-8(11)7-4-2-1-3-5-7/h1-5,8,11H,6H2,(H2,10,12)

| StdInChIKey = OCSOHUROTFFTFO-UHFFFAOYSA-N

}}

Styramate (brand name Sinaxar) is a muscle relaxant and anticonvulsant drug. At therapeutic doses, it does not produce significant sedative effects.

See also

Further reading

{{refbegin}}

  • {{cite journal | vauthors = De Salva S, Evans R | title = Anticonvulsive character of styramate and other depressant drugs | journal = Toxicology and Applied Pharmacology | volume = 2 | issue = 4 | pages = 397–402 | date = July 1960 | pmid = 13815010 | doi = 10.1016/0041-008X(60)90006-5 }}
  • {{cite journal | vauthors = Billow BW, Martorella FJ, Paley SS | title = Clinical experiences with styramate, a nonsedative skeletal muscle relaxant | journal = International Record of Medicine | volume = 173 | pages = 35–8 | date = January 1960 | pmid = 13800722 }}

{{refend}}

{{Muscle relaxants}}

{{GABAAR PAMs}}

Category:Carbamates

Category:GABAA receptor positive allosteric modulators

{{musculoskeletal-drug-stub}}